StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.96−0.16 (-3.88%)

Close on Nov 17, 2026Market cap $317.61MP/E –Yield –

Atea Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Atea Pharmaceuticals's price to book ratio was 1.7× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.4× to 2.1×, with a median of 0.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×+0.8
2025Dec 31, 20250.9×+0.3
2024Dec 31, 20240.6×+0.2
2023Dec 29, 20230.4×−0.2
2022Dec 30, 20220.6×−0.7
2021Dec 31, 20211.3×–

More Atea Pharmaceuticals figures

See a number that looks wrong?